1-160030645-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_145167.3(PIGM):c.1095T>A(p.Phe365Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.166 in 1,614,028 control chromosomes in the GnomAD database, including 24,426 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_145167.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGM | NM_145167.3 | c.1095T>A | p.Phe365Leu | missense_variant | 1/1 | ENST00000368090.5 | NP_660150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGM | ENST00000368090.5 | c.1095T>A | p.Phe365Leu | missense_variant | 1/1 | NM_145167.3 | ENSP00000357069 | P1 |
Frequencies
GnomAD3 genomes AF: 0.127 AC: 19372AN: 152182Hom.: 1635 Cov.: 32
GnomAD3 exomes AF: 0.144 AC: 36184AN: 251442Hom.: 3103 AF XY: 0.144 AC XY: 19567AN XY: 135900
GnomAD4 exome AF: 0.170 AC: 249142AN: 1461728Hom.: 22791 Cov.: 33 AF XY: 0.169 AC XY: 122626AN XY: 727186
GnomAD4 genome AF: 0.127 AC: 19379AN: 152300Hom.: 1635 Cov.: 32 AF XY: 0.125 AC XY: 9304AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2018 | - - |
Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at